2018
DOI: 10.1016/j.cjca.2018.07.242
|View full text |Cite
|
Sign up to set email alerts
|

Can Pulmonary Autograft Dilatation Be Prevented in Patients With Aortic Regurgitation Undergoing the Ross Procedure? Impact of a Tailored Surgical Approach

Abstract: BACKGROUND: Current guidelines recommend ticagrelor or prasugrel as first line agents in the context of patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). De-escalation from ticagrelor or prasugrel to clopidogrel, is a common occurrence in clinical practice. However, inappropriate de-escalation, especially when a change between potent agents is an option may put patients at risk of ischemic complications. There is a paucity of data to indicate whether patients are appro… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles